RecruitingPhase 3NCT06496971

A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

Studying Embryonal tumor of neuroepithelial tissue

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
NaviFUS Corporation
Intervention
Bevacizumab(drug)
Enrollment
32 target
Eligibility
18-80 years · All sexes
Timeline
20242027

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06496971 on ClinicalTrials.gov

Other trials for Embryonal tumor of neuroepithelial tissue

Additional recruiting or active studies for the same condition.

See all trials for Embryonal tumor of neuroepithelial tissue

← Back to all trials